Supply of Illumina MiSeq i100 Whole Genome Sequencing System

The contract involves the procurement and delivery of an advanced Illumina MiSeq i100 Whole Genome Sequencing System, which utilizes sequencing-by-synthesis technology. This system supports both single-read and paired-end libraries, offering a high output capacity of up to 25 gigabases with read lengths of 2x300 base pairs and a base quality score of at least 85% Q30, ensuring accurate and efficient genome sequencing. Issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, this subcontract aims to enhance genomic sequencing capabilities. The contract was posted on May 15, 2026, with a response deadline set for May 22, 2026, at 2:30 PM. It falls under NAICS code 334516, which pertains to manufacturing and supplying electronic measuring instruments. Specific details about the place of performance and points of contact were not provided.